Osemozotan, formerly known as MCI-242; MKC-242; MN-305, 5-HT1A receptor agonist potentially for the treatment of generalized anxiety disorder. Osemozotan is being investigated in its usage to treat pain, aggressive behavior, anxiety, depression, obsessive-compulsive disorder, and drug dependence with methamphetamine and cocaine. References: Matsuda T. Neuropharmacologic studies on the brain serotonin1A receptor using the selective agonist osemozotan. Biol Pharm Bull. 2013;36(12):1871-82. Review. PubMed PMID: 24292048.

纯度：≥98%

CAS：137275-80-0